BLACK WEEKSVials −15% · kits −10% · rest −5%met codeGratis verzending binnen Duitsland vanaf €200

Deze pagina is automatisch vertaald en kan fouten bevatten. Ben je moedertaalspreker? We horen graag je feedback en verbeteringen.Feedback sturen

The Peptide Desk The Peptide Desk
ACE-031, productfoto
Muscle Building

ACE-031

Muscle Building

  • Verzonden vanuit Duitsland

Bestelling

Stukprijs - Gratis verzending binnen Duitsland vanaf €200 tijdens de Black Weeks
  • DHL met tracking
  • Discrete verpakking

4.6 van 5 op Trustpilot73 reviews

In één oogopslag

ACE-031 in cijfers

De kerncijfers uit ons lexicon.

Volledig lexiconartikel
Class
ActRIIB-Fcmyostatin/activin trap
Half-life
longfusion protein
Use
Subcutaneousno established protocol
Sizes
1 mg1 size in the shop

Er is nog geen labanalyse voor ACE-031. Stem eropLaat het zelf testen, wij betalen de helftAlle labanalyses

Kennis

Alles over ACE-031

Uitgebreide informatie volgt binnenkort.

Dosering

Doseringsinformatie laden …

Meer in het lexicon

Handig om erbij te hebben

Wat je erbij nodig hebt

Bacteriostatisch water wordt automatisch aan je winkelwagen toegevoegd. Spuiten en doekjes met één klik.

Insulinespuiten

10 stuks · 5.50 €

Alcoholdoekjes

50 stuks · 10 €

Hoeveel water?

Eenheden op de spuit voor jouw vialgrootte.

Naar de calculator →

FAQ

Veelgestelde vragen

Bronnen bij elk antwoord: lexiconartikel

Nog een vraag?

Schrijf ons, ons team helpt je verder.

What is ACE-031?

A large fusion protein: the outer part of the activin receptor IIB, linked to a piece of an antibody (IgG1 Fc). It binds myostatin and related messengers in the blood before they reach the receptor on muscle. The compound name is ramatercept.

What did the first human study show?

48 healthy postmenopausal women received a single dose at ascending levels or placebo. In the group with the highest study dose lean mass rose by 3.3 percent and thigh muscle volume by 5.1 percent after 29 days. The half-life was 10 to 15 days.

Why was development stopped?

In the trial in boys with Duchenne muscular dystrophy nosebleeds and telangiectasias occurred, meaning widened small blood vessels. The trial was stopped after the second dosing regimen because of potential safety concerns. The activin receptor IIB acts not only on muscle but also on vessels.

Was there a benefit in Duchenne?

Only trends. The 6-minute walk distance tended to be maintained in the ACE-031 groups while it declined on placebo. There were also trends towards more lean mass and bone density and less fat mass. None of this was statistically significant.

Is ACE-031 approved?

No. ChEMBL lists ramatercept with phase 2 as the highest phase. ClinicalTrials.gov lists four trials from 2008 to 2011, both phase 2 trials were terminated early (as of 26 October 2026).

What do animal studies show?

In marmosets lean mass increased over 14 weeks on ACE-031, muscle fibres became thicker and muscle force rose. This did not happen in the control group. The authors see this as a pointer for muscle diseases in humans.

Gerelateerd

Gerelateerde producten